WO2002044737A3 - Compositions pour applications diagnostiques et therapeutiques et methodes associees au recepteur couple aux proteines g (gpcr) le recepteur anaphylatoxine c3a - Google Patents
Compositions pour applications diagnostiques et therapeutiques et methodes associees au recepteur couple aux proteines g (gpcr) le recepteur anaphylatoxine c3a Download PDFInfo
- Publication number
- WO2002044737A3 WO2002044737A3 PCT/US2001/045220 US0145220W WO0244737A3 WO 2002044737 A3 WO2002044737 A3 WO 2002044737A3 US 0145220 W US0145220 W US 0145220W WO 0244737 A3 WO0244737 A3 WO 0244737A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- anaphylatoxin
- receptor
- diagnostic
- therapeutic compositions
- methods related
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Psychology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002239417A AU2002239417A1 (en) | 2000-11-29 | 2001-11-29 | Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor |
US10/206,395 US20030157570A1 (en) | 2001-10-17 | 2002-07-26 | Diagnostic and therapeutic compositions and methods related to G protein-coupled receptor (GPCR) anaphylatoxin C3a receptor |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25025100P | 2000-11-29 | 2000-11-29 | |
US60/250,251 | 2000-11-29 | ||
US25045200P | 2000-11-30 | 2000-11-30 | |
US60/250,452 | 2000-11-30 | ||
US33003601P | 2001-10-17 | 2001-10-17 | |
US60/330,036 | 2001-10-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002044737A2 WO2002044737A2 (fr) | 2002-06-06 |
WO2002044737A3 true WO2002044737A3 (fr) | 2003-05-15 |
Family
ID=27400298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/045220 WO2002044737A2 (fr) | 2000-11-29 | 2001-11-29 | Compositions pour applications diagnostiques et therapeutiques et methodes associees au recepteur couple aux proteines g (gpcr) le recepteur anaphylatoxine c3a |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002239417A1 (fr) |
WO (1) | WO2002044737A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002044737A2 (fr) * | 2000-11-29 | 2002-06-06 | Lifespan Biosciences, Inc. | Compositions pour applications diagnostiques et therapeutiques et methodes associees au recepteur couple aux proteines g (gpcr) le recepteur anaphylatoxine c3a |
WO2004082566A2 (fr) * | 2003-03-17 | 2004-09-30 | Bayer Healthcare Ag | Methodes diagnostiques et therapeutiques de maladies associees au recepteur 1 du composant de complement 3a (c3ar1) |
WO2005101013A2 (fr) * | 2004-04-15 | 2005-10-27 | Reglia Ab | Substances et procedes pour le criblage de modulateurs de la regeneration neuronale |
EP2510949A4 (fr) | 2009-12-11 | 2013-11-13 | Astellas Pharma Inc | Agent thérapeutique pour la fibromyalgie |
GB201619637D0 (en) | 2016-11-21 | 2017-01-04 | Pekna Marcela And Pekny Milos And Stokowska Anna | C3a receptor agonists |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999015490A1 (fr) * | 1997-09-23 | 1999-04-01 | Smithkline Beecham Corporation | Ligands pour recepteurs de c3a |
US5942405A (en) * | 1996-06-17 | 1999-08-24 | Smithkline Beecham Corporation | Therapeutic and screening methods using C3a receptor and C3a |
US5989592A (en) * | 1996-10-03 | 1999-11-23 | Coastside Bio Resources | Inhibition of complement pathway by sea cucumber fractions |
WO2002044737A2 (fr) * | 2000-11-29 | 2002-06-06 | Lifespan Biosciences, Inc. | Compositions pour applications diagnostiques et therapeutiques et methodes associees au recepteur couple aux proteines g (gpcr) le recepteur anaphylatoxine c3a |
-
2001
- 2001-11-29 WO PCT/US2001/045220 patent/WO2002044737A2/fr not_active Application Discontinuation
- 2001-11-29 AU AU2002239417A patent/AU2002239417A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5942405A (en) * | 1996-06-17 | 1999-08-24 | Smithkline Beecham Corporation | Therapeutic and screening methods using C3a receptor and C3a |
US5989592A (en) * | 1996-10-03 | 1999-11-23 | Coastside Bio Resources | Inhibition of complement pathway by sea cucumber fractions |
WO1999015490A1 (fr) * | 1997-09-23 | 1999-04-01 | Smithkline Beecham Corporation | Ligands pour recepteurs de c3a |
WO2002044737A2 (fr) * | 2000-11-29 | 2002-06-06 | Lifespan Biosciences, Inc. | Compositions pour applications diagnostiques et therapeutiques et methodes associees au recepteur couple aux proteines g (gpcr) le recepteur anaphylatoxine c3a |
Non-Patent Citations (2)
Title |
---|
KRETZSCHMAR T ET AL: "Synthetic peptides as antagonists of the anaphylatoxin C3a", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 210, no. 1, 15 November 1992 (1992-11-15), pages 185 - 191, XP002116090, ISSN: 0014-2956 * |
ROGLIC A ET AL: "CDNA CLANING OF A NOVEL G PROTEIN-COUPLED RECEPTOR WITH A LARGE EXTRACELLULAR LOOP STRUCTURE", BIOCHIMICA ET BIOPHYSICA ACTA, AMSTERDAM, NL, vol. 1305, 1996, pages 39 - 43, XP000609693, ISSN: 0006-3002 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002239417A1 (en) | 2002-06-11 |
WO2002044737A2 (fr) | 2002-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
WO2005014035A3 (fr) | Utilisation de galactose oxydase pour la conjugaison chimique selective de molecules d'extraction a des proteines d'interet therapeutique | |
ATE269402T1 (de) | Ikk-beta proteine, nukleinsäuren und verfahren | |
WO2003057837A3 (fr) | Procedes d'utilisation d'anticorps anti-muc18 | |
WO2002008285A3 (fr) | Molecules il-17 et leurs utilisations | |
WO2000073469A3 (fr) | Proteines kinases | |
MXPA03002413A (es) | Moleculas tipo b7 y uso de las mismas. | |
WO2001070977A3 (fr) | Molecules analogues au recepteur du facteur de croissance du fibroblaste, et leurs utilisations | |
WO2002014500A3 (fr) | Genes humains et produits d'expression genique | |
WO2001066753A3 (fr) | Nouveaux genes humains et leurs produits d'expression | |
WO2002000724A3 (fr) | Molecules de recepteur de lymphopoietine de stroma thymique et utilisations de celles-ci | |
WO2001061007A3 (fr) | Molecules du facteur 23 de croissance de fibroblastes et procedes d'utilisation correspondants | |
WO2001068859A3 (fr) | Molecules du type recepteur de l'interleukine 17 et leur utilisation | |
WO2001055178A3 (fr) | Compositions et methodes de traitement de cancer | |
WO2001068854A3 (fr) | Molecules s'apparentant au facteur de croissance des fibroblastes et leurs utilisations | |
WO2001042474A3 (fr) | Molecules de type interferon et utilisations | |
WO2002044737A3 (fr) | Compositions pour applications diagnostiques et therapeutiques et methodes associees au recepteur couple aux proteines g (gpcr) le recepteur anaphylatoxine c3a | |
WO2001057219A3 (fr) | Cytokines mammaliennes, leurs recepteurs, reactifs et procedes correspondants | |
WO2005019259A3 (fr) | Variants de l'antagoniste du recepteur d'interleukine-1: compositions et utilisations correspondantes | |
EP2088197A3 (fr) | Antigènes de Haemophilus influenzae et fragments d'ADN correspondants | |
WO1999066051A3 (fr) | Kinases en rapport avec nek et avec bub1 | |
WO2003076658A3 (fr) | Gene de predisposition a la maladie de parkinson idiopathique a apparition tardive | |
PL374550A1 (en) | Il-17 like molecules and uses thereof | |
MXPA03010728A (es) | Moleculas de proteina-2 relacionadas con b7 y uso de las mismas. | |
WO2001074903A3 (fr) | Molecules du type recepteur de cd20/ige et leurs applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |